Could two doses of a dialysis fluid help Kids' hearts and kidneys?
NCT ID NCT07168343
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using two daily exchanges of a special dialysis fluid called icodextrin can better control fluid buildup and blood pressure in children on chronic peritoneal dialysis. Ten children aged 5-18 will be enrolled. The goal is to see if this approach improves fluid removal and reduces the need for blood pressure medications, while also checking if it adds extra burden on caregivers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
icodextrin
What this could lead to
If it works, this could point toward a better way to manage fluid overload and blood pressure in children on dialysis, potentially reducing hospital visits.
What could go wrong
This is a very small, early trial with only 10 children. The added exchange may increase caregiver burden and might not improve outcomes. Results may not apply to all children on dialysis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDREN ON CHRONIC PERITONEAL DIALYSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National University Hospital
Singapore, Singapore